LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 6.06 | 84.90 | 654 | 365 | 1.7896 | 1.6366 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 7.77 | 84.90 | 665 | 411 | 1.6171 | 1.4702 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 7.77 | 84.90 | 686 | 411 | 1.6681 | 1.5042 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 9.47 | 84.90 | 710 | 447 | 1.5868 | 1.4247 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 9.47 | 84.90 | 734 | 447 | 1.6405 | 1.4586 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 11.18 | 84.90 | 725 | 492 | 1.4725 | 1.3297 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 11.18 | 84.90 | 2 | 492 | 0.0041 | -0.7719 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 11.18 | 84.90 | 760 | 492 | 1.5436 | 1.3734 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 12.88 | 84.90 | 1 | 531 | 0.0019 | -0.8135 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 12.88 | 84.90 | 757 | 531 | 1.4256 | 1.2869 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 12.88 | 84.90 | 13 | 531 | 0.0245 | -0.5081 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 12.88 | 84.90 | 814 | 531 | 1.5330 | 1.3506 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 14.58 | 84.90 | 59 | 663 | 0.0889 | -0.1155 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 14.58 | 84.90 | 793 | 663 | 1.1953 | 1.1240 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 14.58 | 84.90 | 42 | 663 | 0.0633 | -0.2112 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 14.58 | 84.90 | 818 | 663 | 1.2330 | 1.1464 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 16.29 | 84.90 | 157 | 766 | 0.2047 | 0.2137 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 16.29 | 84.90 | 820 | 766 | 1.0693 | 1.0427 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 16.29 | 84.90 | 234 | 766 | 0.3051 | 0.3762 | MN20160318_Q02 | N03 |